874 results on '"Savignoni, A."'
Search Results
2. Hemodynamic Assessment of a Large Pulmonary Arteriovenous Malformation in a Neonate: Case Report and Review of Literature
3. Anterolateral congenital tibial bowing: case report
4. Impact of body mass index on overall survival in patients with metastatic breast cancer
5. A Question Prompt List for Advanced Cancer Patients Promoting Advance Care Planning: A French Randomized Trial
6. Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
7. Impact of body mass index on overall survival in patients with metastatic breast cancer
8. Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelines
9. Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study
10. Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study
11. Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study
12. Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
13. Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
14. Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database
15. Iterative treatment with surgery and radiofrequency ablation of uveal melanoma liver metastasis: Retrospective analysis of a series of very long-term survivors
16. Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
17. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy
18. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcomeResearch in context
19. Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.
20. Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
21. Changes in Breathing Patterns after Surgery in Severe Laryngomalacia
22. Anterolateral congenital tibial bowing: case report
23. 6 supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
24. Legends to supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
25. Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
26. 6 supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
27. Data from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
28. Legends to supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
29. Neurodevelopmental outcomes of infants with Vein of Galen aneurismatic malformation
30. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009)
31. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer
32. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study
33. 319TiP NeoBREASTIM: A phase II study of atezolizumab plus RP1 oncolytic immunotherapy in the neoadjuvant setting of triple-negative breast cancer (TNBC)
34. Severe herpes virus 6 interstitial pneumonia in an infant with three variants in genes predisposing to lung disease
35. Pattern of relapse in low‐risk breast cancer patients followed within a community care network
36. Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer
37. Histological changes of semitendinosus autograft after anterior cruciate ligament reconstruction in an immature rabbit model
38. Early together: A randomized phase III study of early palliative care in metastatic uveal melanoma (MUM).
39. Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation
40. Locoregional Treatment for Breast Carcinoma After Hodgkin's Lymphoma: The Breast Conservation Option
41. Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
42. Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelines
43. Hemodynamic Assessment of a Large Pulmonary Arteriovenous Malformation in a Neonate: Case Report and Review of Literature
44. Neurodevelopmental outcomes of infants with Vein of Galen aneurismatic malformation
45. Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
46. Traitement locorégional du cancer du sein inflammatoire après chimiothérapie néoadjuvante
47. Cancers du sein de stade II-IIIA : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?
48. Is Radiotherapy an Option for Early Breast Cancers With Complete Clinical Response After Neoadjuvant Chemotherapy?
49. Management of Inflammatory Breast Cancer After Neoadjuvant Chemotherapy
50. Changes in Breathing Patterns after Surgery in Severe Laryngomalacia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.